Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C P Cross

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Leukemia|June 27, 2015
Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locusA Chase, W Leung, W Tapper, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Leukemia|October 7, 2015
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st studyA Hochhaus, G Rosti, N C P Cross, et al.
Leukemia|April 27, 2013
Mutations and prognosis in primary myelofibrosisA M Vannucchi, T L Lasho, P Guglielmelli, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
The New England Journal of Medicine|October 15, 2011
Somatic SF3B1 mutation in myelodysplasia with ring sideroblastsE Papaemmanuil, M Cazzola, J Boultwood, et al.
The New England Journal of Medicine|December 12, 2013
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2J Nangalia, C E Massie, E J Baxter, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Leukemia|June 27, 2015
Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locusA Chase, W Leung, W Tapper, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Leukemia|October 7, 2015
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st studyA Hochhaus, G Rosti, N C P Cross, et al.
Leukemia|April 27, 2013
Mutations and prognosis in primary myelofibrosisA M Vannucchi, T L Lasho, P Guglielmelli, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
The New England Journal of Medicine|October 15, 2011
Somatic SF3B1 mutation in myelodysplasia with ring sideroblastsE Papaemmanuil, M Cazzola, J Boultwood, et al.
The New England Journal of Medicine|December 12, 2013
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2J Nangalia, C E Massie, E J Baxter, et al.
Pageof 5